Navigation Links
Promise and caution shown in ongoing research into stem cell treatment of strokes
Date:7/9/2013

DETROIT While stem-cell therapy offers great promise for the treatment of stroke, much research remains to be done to show its long-term effectiveness and to understand the potential for dangerous side effects.

These are the conclusions drawn by Henry Ford Hospital neurologists Jing Zhang, M.D., Ph.D., and Michael Chopp, Ph.D., scientific director of the Henry Ford Hospital Neuroscience Institute, in a review of their own and other current research into the next-generation treatment of one of the leading causes of death and disability around the world. The article has been accepted for publication by Expert Opinion on Biological Therapy.

Most strokes are ischemic, meaning they occur when an artery to the brain is blocked, stopping the flow of vital, oxygen-rich blood. The blockage can be caused by a blood clot, air bubble or other mass in the blood stream.

"This touches off many complicated reactions," Dr. Zhang explains. "Nerve circuits are disrupted. Chemical processes within cells are disturbed. The blood-brain barrier, which protects the brain from a wide range of harmful invasions, including infection, is damaged.

"As a result, many stroke survivors are left with permanent neurological and physical disability. And this leads to a huge social and economic burden."

Current stroke treatment focuses on restoring blood flow to the brain to stop further cell and tissue damage. However, Drs. Zhang and Chopp write, only one drug has FDA approval for the clinical treatment of stroke.

Called tPA, it's an enzyme that works on destroying or dissolving the blockage that caused the stroke. Although it can be effective, it also has downsides, they note.

The time in which tPA can be helpful is short at most only four and a half hours after the stroke. This is probably the reason less than 10 percent of stroke patients are treated with tPA.

The drug also has its own dangers, the Henry Ford researchers note. It can cause bleeding in the brain and, if it succeeds in opening the blockage, the restored blood flow itself can cause more tissue damage by increasing inflammation and the destructive molecules known as free radicals.

In contrast to this current, flawed treatment, research into stem-cell therapy focuses on restoring or enhancing the central nervous system's ability to heal itself.

Transplanted stem cells enter the damaged brain and work as a "biofactory" that stimulates and increases this self-healing. Among other processes, this includes the formation of new nerve and brain cells, the sprouting of capillaries from existing blood vessels and repair of the blood-brain barrier, Drs. Zhang and Chopp write.

But there is still far too much to learn before such therapy can safely and effectively be used in humans, according to the review paper. For example:

  • What types of stem cells offer the most effective treatment? Each has to be thoroughly investigated for benefits and risks.
  • What "treatment window" or time limit for maximum effectiveness goes with them?
  • When and how should they be administered and by what route?
  • Which characteristics of stroke patients, including other diseases or disorders, have to be taken into account and how?

"Well-designed investigations into the benefits and risks of each type of stem cell, each candidate for safe and effective treatment of stroke patients, must be done before we can consider them for clinical use," Chopp says.

"But their promise is remarkable."


'/>"/>

Contact: Dwight Angell
dwight.angell@hfhs.org
313-850-3471
Henry Ford Health System
Source:Eurekalert

Related medicine news :

1. Early Study Finds Some Promise for Lung Cancer Vaccine
2. Novel compound demonstrates anti-leukemic effect in zebrafish, shows promise for human treatment
3. Nonsurgical Method to Measure Brain Pressure Shows Promise
4. Immunotherapy for elderly cancer patients finds new promise in drug combination
5. Experimental Pill for Multiple Sclerosis Shows Promise
6. Mechanical tissue resuscitation technology shows promise
7. Brain Tumor Vaccine Shows Promise in Early Trial
8. New Method to Reveal Alzheimers Marker Shows Promise
9. Detecting malaria early to save lives: New optical technique promises rapid and accurate diagnosis
10. New Drug Shows Promise for Myeloma Patients
11. New Weight-Loss Drug Shows Promise in Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2017)... (PRWEB) , ... August 20, 2017 , ... State Farm ... of 40 national causes up for a $25,000 grant. If the initiative wins, Gals ... bullying – will expand into the Tri-County area of St. Mary’s, Calvert and Charles ...
(Date:8/19/2017)... ... August 18, 2017 , ... President Donald Trump signed into ... provides for greater public access to over-the-counter (OTC) hearing aids. , The measure ... aids without being seen by a certified and licensed audiologist. , “The ...
(Date:8/19/2017)... ... August 19, 2017 , ... ... diverse community of over 1,000 passionate employees, caregivers, volunteers, thought leaders, researchers, educators ... Stonegate changed ownership, it was time to refresh the carpeting with the goal ...
(Date:8/18/2017)... , ... ... ... For Immediate Release                Contact: ... Shows Young Women Seek Sex and Relationship Advice from their ...
(Date:8/18/2017)... Ca (PRWEB) , ... August 18, 2017 , ... ... quality liquid handling handheld devices. Through an educational webinar, they will present the ... users a chance to learn how easy you can automate everyday pipetting tasks. ...
Breaking Medicine News(10 mins):
(Date:7/27/2017)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported ... The Company reported second quarter net sales of $1.954 ... period, and an increase of 2.1% on a constant ... from the LDR Holding Corporation acquisition, second quarter 2017 ... or 0.3% on a constant currency basis. ...
(Date:7/26/2017)... -- E.I. Medical Imaging (EIMI) has partnered with Dr. ... the worlds first ultrasound system to be used underwater to ... In preparation for a piece produced by Icon films ... Guttridge approached EIMI with the idea of an underwater ultrasound ... underwater. EIMI produces ...
(Date:7/26/2017)... RIVIERA BEACH, Fla. , July 26, 2017 /PRNewswire/ ... completion of enrollment of our clinical trial evaluating Altemia ... Sickle Cell Anemia (SCA) and Sickle Cell Disease (SCD). ... study to evaluate the efficacy and safety of Altemia ... This trial is conducted under US IND 125274. ...
Breaking Medicine Technology: